Management Team

Pete DeComo Peter M. DeComo, the Chairman and Chief Executive Officer founded and shepherded Renal Solutions to a $200 million acquisition by Fresenius Medical Care in late 2007. In addition, he is a registered respiratory therapist, and has an extensive background in extracorporeal therapies.
Rachel Allen Rachel Allen, General Counsel has over 20 years of experience acting as the principal outside lawyer on numerous completed M&A, venture capital, and private equity transactions in a variety of industries, including health care, medical device, and energy.
Joe Argyros Joseph Argyros, Senior Vice President – Operations has extensive experience in leading medical device product development, manufacturing and service operations. He has held senior positions in these capacities at Neuro Kinetics and Nomos.
David Haffner David J. Haffner, Senior Vice President and Chief Financial Officer recently served as CFO of Foundation Radiology, ClearCount Medical Solutions and NOMOS Corporation, all venture backed medical device companies. He is a CPA and received a BS degree in Accounting and Management Information Systems from the Pennsylvania State University.
jeremy_kimmel Jeremy D. Kimmel, PhD, Vice President of New Technology has extensive experience in research and development of blood purification devices for the critically ill. Prior to ALung, Dr. Kimmel developed advanced medical technologies at the University of Pittsburgh and Pall Corporation.
Frank Falcione Frank J. Falcione, Senior Vice President – Regulatory Affairs and Quality Assurance has extensive experience in FDA submissions and ISO quality system implementation. He has held senior positions in these capacities at CHS Business Associates, Emerson and Chiron Diagnostics.
Laura Lund Laura W. Lund, PhD, Vice President – Clinical and Scientific Affairs has extensive experience in the research, design, and validation of blood gas exchange technology. Prior to ALung, Dr. Lund was an assistant professor in the Department of Bioengineering at the University of Pittsburgh’s Swanson School of Engineering.
 Scott Morley Scott Morley, Vice President of Business Development has an extensive background in biomedical engineering, clinical affairs, and marketing having held senior positions in these roles at ALung. He has been with the Company since 2003.




Nausherwan Burki, M.D., Ph.D., Medical Director and Chairman of the Medical Advisory Board, is Professor, Department of Medicine, Division of Pulmonary & Critical Care Medicine at the University of Connecticut Health Center, Farmington, Connecticut. As a physician-scientist with expertise in both the physiology and treatment of lung disease, Dr. Burki directs the Company’s clinical research programs.

William Federspiel, Ph.D., Chairman of the Scientific Advisory Board and co-founder, is the Director of the Medical Devices Laboratory, McGowan Institute for Regenerative Medicine, University of Pittsburgh where he is a William Kepler Whiteford Professor of Bioengineering, Chemical Engineering, and Critical Care Medicine.

Board of Directors


Peter M. DeComo, Chairman and Chief Executive Officer.

Nicholas Cullen, a board member, is a former Executive Vice President of Bayer Corporation, and former President of its Plastics Division. His primary responsibilies were in marketing, sales, and business management at Bayer with focus on polyurethanes, coatings, and plastics.

Gary G. Glausser, a board member, is the Chief Investment Officer of Innovation Works (IW). Gary oversees IW’s investment fund(s), chairs its Investment Committee and helps IW source, evaluate and invest in the region’s most promising startups. He is also General Partner at Birchmere Ventures a fully invested venture capital fund with $160 million under management. Mr. Glausser has over 30 years experience in financial management, investing, lending, and public accounting.

Gerald E. McGinnis, a board member, is the founder and former Chairman of Respironics, a company he sold to Philips Medical for $5.1 billion in 2008. He has career-long experience in pulmonary products, both in home and hospital care.

John McIlwraith, a board member, is a Managing Director at Allos Ventures, an early-stage venture capital firm.

Kraig McEwen, a board member, is President of Aesynt, formerly McKesson Automation, Inc. (MAI). Prior to Aesynt, Kraig was President and CEO of CardiacAssist and Senior Vice President of Medrad Inc.

David Motley, a board member, is a General Partner at Blue Tree Venture Fund. He is also a Senior Managing Director at Headwaters|SC, and former VP and GM at Respironics and Covidien.